Next Article in Journal
Molecular Characterization of Propolis-Resistant Saccharomyces cerevisiae Obtained by Evolutionary Engineering
Previous Article in Journal
Lipid Production in Streptomyces jeddahensis Is Enhanced by Glucose and Fatty Acid Derivatives, with Temperature Variations Influencing Gene Expression and Biosynthesis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Advances in Biological Production of D-Tagatose: A Comprehensive Overview

1
College of Life Sciences, Linyi University, Linyi 276000, China
2
College of Chemistry and Chemical Engineering, Linyi University, Linyi 276000, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Fermentation 2025, 11(2), 46; https://doi.org/10.3390/fermentation11020046
Submission received: 22 November 2024 / Revised: 14 January 2025 / Accepted: 17 January 2025 / Published: 21 January 2025
(This article belongs to the Section Microbial Metabolism, Physiology & Genetics)

Abstract

:
D-tagatose is a rare, naturally occurring low-calorie hexose, with a sweetness of 92% sucrose but only 1/3 of the calories. It has beneficial functions in lowering blood sugar, controlling obesity, preventing dental caries, and improving intestinal flora. In recent years, biotechnological routes to D-tagatose production from renewable raw materials have been regarded as very promising approaches. In this review, we provide an overview of the properties and applications of D-tagatose, with a focus on the current developments in the production of D-tagatose using enzymatic transformation and whole-cell catalytic synthesis. The biosynthetic pathways and the types and characteristics of the catalytic enzymes involved have been summarized, providing a reference for the design of D-tagatose synthesis pathways. We also expect that rapid developments in the fields of systems biology and synthetic biology will accelerate protein and metabolic engineering for microbial D-tagatose production in the future.

1. Introduction

In recent years, sugar intake has become a major public health issue and is becoming increasingly popular among people of all ages. However, excessive sugar intake increases the risk of metabolic diseases, including diabetes, dental caries, obesity, and other health problems [1,2]. Due to people’s demand for nutrition and health, it has been discovered that sugar substitutes, which can be used as substitutes to maintain sugar intake, can benefit consumers by reducing calorie and sugar intake [3]. The U.S. Food and Drug Administration (FDA) has stated that the use of artificial sweeteners within the acceptable daily intake (ADI) range is safe [4]. Nowadays, sugar substitutes have been widely used in the food, medical, and cosmetics industries [5,6], and 25% of children and 41% of adults use sugar substitutes in the United States [7]. According to statistics, the global market size of sugar substitutes reached USD 18.96 billion in 2022, and the popularity of sugar substitutes has been continuously increasing [8].
Sugar substitutes are divided into natural and artificial substitutes according to their sources and processing methods. Artificial sugar substitutes are made through chemical synthesis and have the advantages of high sweetness, low calories, and good stability, and include saccharin, aspartame, sucralose, etc. Compared with artificial substitutes, natural sugar substitutes have higher safety and are unanimously considered a more promising type of sweetener [9,10].
In natural sugar substitutes, those with the broadest market prospects include stevia [11], D-allulose [12], D-tagatose [13], and Brazilian sweet protein [14], among others. Stevia has a sweetness 200–300 times that of sucrose, with only about 1/250 of the calories. However, compared to sucrose, stevia exhibits a noticeable aftertaste of bitterness, which affects its further application [15]. D-allulose is a type of monosaccharide that exists naturally but in very small amounts. It has a sweetness level of 70% that of sucrose, yet contains only 0.3% of the calories of sucrose, boasting advantages such as a low calorie content, high stability, and non-hygroscopicity. With the further improvement of production efficiency driven by synthetic biology, its market size is gradually expanding [16]. Brazilian sweet protein is a sweet-tasting protein extracted from the fruit of a wild plant native to West Africa. With a sweetness intensity ranging from 500 to 2000 times that of sucrose, it is one of the sweetest natural substances known to date, devoid of metallic or bitter aftertaste, and offering advantages such as long-lasting sweetness and flavor enhancement [17]. Due to the high cost of traditional plant extraction methods, the development of a biological fermentation process for the production of Brazilian sweet protein is urgently needed.
D-tagatose is a naturally occurring rare monosaccharide with a structure similar to D-allulose. Its sweetness is 92% that of sucrose, and it contains only one-third of the calories of sucrose. As a natural sugar substitute, D-tagatose is a substance derived from the gum of a tropical evergreen tree called Sterculia setigera, and it has also been found in limited amounts in lower plants, including mosses and lichens, and in other dairy products exposed to heat [18,19,20]. Studies have shown that D-tagatose can inhibit oral bacterial growth by affecting glycolysis and its downstream metabolism [21], so it has great potential for preventing oral diseases [22].
In 2022, the global D-tagatose market reached hundreds of millions of dollars and is projected to continue growing at a compound annual growth rate of 6%. The market agencies predict that the global tagatose market size will expand from USD 155 million in 2023 to USD 243 million by 2033. However, with the increase in market demand, effective methods for D-tagatose production have become an urgent issue. Currently, the main producers of D-tagatose include Sukrin (Suriname), Living Fuel (U.S.), Damhert Nutrition NV (Belgium), CJ Cheiljedang Corporation (Korea), Bonumose (U.S.), Linlu Biotechnology (China), and other companies. The methods of production of D-tagatose mainly include chemical synthesis and biological methods [23,24]. Chemical synthesis involves using soluble alkali metal or alkaline earth metal salts as catalysts to promote the formation of D-tagatose from D-galactose under alkaline conditions, resulting in a metal hydroxide–tagatose complex, which is then neutralized with acid to obtain D-tagatose [25]. CJ Cheiljedang Corporation employs this method, with an annual production capacity exceeding 3000 tons of D-tagatose. Although chemical synthesis has achieved industrial production, they have many unfavorable production factors—for example, the production of many chemical pollutants and by-products under alkaline conditions, complex production processes, high energy consumption of intermediates, environmental pollution, etc. [26]. The biological method for producing D-tagatose utilizes biological enzymes or enzyme-containing cells as catalysts to catalyze the conversion of substrates into D-tagatose at a certain concentration, followed by separation and purification to obtain the D-tagatose product. Biosynthesis offers mild reaction conditions, safety, high efficiency, and production of the least amount of by-products, and is currently the mainstream research approach [27]. Currently, Linlu Biotechnology (Huang shi, China) Co., Ltd., has reached a production capacity of 2000 tons of D-tagatose using the bioconversion method. In this review, we primarily focus on the research progress of biological production of D-tagatose and divide it into two types: in vitro enzymatic conversion and whole-cell catalytic synthesis. For each class, we summarize the synthetic pathway, the enzymes and its sources, substrate specificity, and catalytic efficiency. Finally, we discuss further improvements needed for the production of D-tagatose using protein engineering, systems biology, and synthetic biology strategies.

2. Overview of D-Tagatose

2.1. Structure and Physicochemical Properties of D-Tagatose

As a food sweetener, D-tagatose has 92% of the sweetness of sucrose, but the calorific value is only 1.5 kcal/g, which is 30% of the calorific value of sucrose [13]. The molecular formula of D-tagatose is C6H12O6 and it has a relative molecular mass of 180.16 g/mol [28], which is the isomer of D-galactose, the C-3 diastereoisomer of D-sorbose and the C-4 diastereoisomer of D-fructose (Figure 1) [6]. Pure D-tagatose is a white crystalline substance with no particular smell and a melting point of 134 °C. It is readily soluble in water and slightly soluble in ethanol [19], and the solubility of D-tagatose is 58% at room temperature [26]. This reducing sugar has a low hygroscopicity but a high moisturizing capacity and stability. Similar to other monosaccharides, D-tagatose remains stable within the pH range of 3–7. Minimal loss of D-tagatose and browning were observed in citrate and phosphate buffers at pH 3.0. Furthermore, at 40 °C and in 0.1 M buffer (pH 3.0), a significant loss of approximately 5% of D-tagatose was observed over a period of more than six months, with a slight browning color [29].
D-tagatose has also some alkalinity and heat resistance but is susceptible to the Maillard reaction at high temperature [30]. D-tagatose reacts with amino acids in a Maillard reaction to produce volatile substances such as 2-acetylfuran, 2-ethylpyrazine, and 2-acetylthiazole, which are more volatile than reducing sugars such as D-glucose and D-galactose [28]. These unique features enable D-tagatose to interact with other sweetening substances, such as stevia and sucralose, resulting in a more desirable sweetness perception through synergistic effects [31]. Saunders et al. showed in a study with mice that 68% of D-tagatose was finally broken down to CO2 [32]. Kruger et al. conducted a tartar feeding experiment on mice and found that D-tagatose did not cause chronic or genotoxic lesions in mice at the experimental dose and was therefore safe and reliable for use as food. Other extensive safety toxicology studies on D-tagatose have also shown that it is safe and harmless to consume [33].

2.2. Physiological Function and Applications of D-Tagatose

Based on the physicochemical properties of D-tagatose mentioned above, it has the following four major functions: hypoglycemia [29], low energy consumption [34], improvement of intestinal flora [25], and caries prevention (Table 1) [35]. Studies have shown that only a small fraction (20–25%) of the D-tagatose that enters the body is digested and absorbed in the small intestine, and that it also inhibits the absorption of D-glucose in the small intestine, thus effectively suppressing an increase in blood glucose in patients with diabetes and reducing the chance of related complications [23]. D-tagatose can be catabolized by the 6-phosphate tagatose pathway, but this pathway is only present in specific microorganisms [36]. Furthermore, during the metabolic process, a part of the energy is lost due to the increased excretion of biomass from the flora [37]. Therefore, the energy produced by the decomposition and metabolism of D-tagatose is much lower than that of sucrose, which is beneficial for reducing food calories and obesity [38]. In addition to reduced absorption in the small intestine, D-tagatose is hardly broken down and utilized by microorganisms in the oral cavity, and trace amounts of D-tagatose that adhere to the tooth surface can form a protective film, thus effectively protecting dental health and preventing dental caries [21,34,35]. Moreover, D-tagatose undergoes selective fermentation in the colon by certain microflora, which stimulates the growth of lactic acid bacteria and Lactobacilli during the fermentation process and inhibits the growth of various pathogenic bacteria in the intestine, resulting in a favorable probiotic effect [25]. Some studies have shown that a daily intake of 4.5 g or more of D-tagatose can significantly improve intestinal flora [39].
In addition to these common functions, studies have shown that D-tagatose has other physiological functions, including the enhancement of crucial blood factors that facilitate the promotion of blood metabolic circulation in humans [40]. It effectively inhibits the harmful effects of chemicals, such as cocaine and furantoin, on the liver, while enhancing the sensitivity of liver cells to toxic substances and acting as a hepatoprotective agent [41]. It improves the chances of pregnancy in female rats and has tremendous potential for the treatment of infertility [33]. It is able to inhibit the growth of numerous microorganisms, and it has been proposed as a promising plant protection product [42].
Based on the characteristics and physiological functions of D-tagatose, it has been granted Generally Recognized as Safe (GRAS) status by the U.S. Food and Drug Administration (FDA) since 2001 [43]. The European Union also approved the marketing of D-tagatose in Europe in 2003, and PepsiCo officially used D-tagatose as a flavor enhancer in Sprite beverages in August 2006, marking the first time D-tagatose entered the commercial arena. In 2007, Miada Sports Nutrition Foods of New Zealand applied D-tagatose to the development of chocolate products, which were released to Australian and New Zealand supermarkets in May. D-tagatose is currently used in large quantities in the U.S. as a substitute for white sugar in health drinks as well as in yogurt and juice products. D-tagatose products are now approved for use by food hygiene authorities in the U.S., Australia, Japan, and Korea.

3. Production of D-Tagatose by Biological Methods

The amount of D-tagatose in nature is extremely low, and therefore it is difficult for naturally extracted D-tagatose to meet the actual production demand. D-lactose, as a relatively inexpensive and abundant raw material, has been used for the industrial production of D-tagatose for the first time [44]. The current method of producing D-tagatose is primarily chemical synthesis, which involves using alkaline metals as catalysts, with D-lactose as the substrate, such as conversion of D-galactose to D-tagatose using a calcium catalyst. Under the catalysis of metal hydroxides and metal salts, the isomerization of D-lactose produces a D-tagatose–metal ion complex intermediate precipitate. Then, the acid neutralization method can be used to separate and purify the D-tagatose [41]. D-lactose can be hydrolyzed to produce D-glucose and D-galactose, and then chemically processed to produce D-tagatose. Although the method has a high yield, it has many disadvantages. Traditional manufacturing methods can only convert about 30% of D-galactose [45], and the cost of separating D-tagatose is high, leading to a persistently high retail price for tagatose. According to data from Dutch industry consulting firm FutureBridge, in 2020, the retail price of D-tagatose was USD 26/kg, while the retail price of sucrose was only USD 0.05/kg. Furthermore, alkaline conditions hinder the isomerization reaction of aldo-ketose. Additionally, the reaction process is prone to browning and the production of a large amount of by-product. This in turn leads to a complicated process of product separation and purification, increasing production costs and causing environmental pollution and resource waste, and the same molar amounts of D-galactose and Ca2+ must be used to obtain high yields of D-tagatose [46]. Severe degradation of D-galactose led to a decrease in D-tagatose yield, while a decrease in syrup quality allowed for the production of D-tagatose. Therefore, it is not a safe or long-term method for the preparation of D-tagatose [47]. Although there are other chemical methods to produce D-tagatose, such as supercritical fluid (<24%) [48], arginine (<16.8%) [49], hydrotalcite (<27%) [50], etc., these methods produced low yields of D-tagatose. Due to these disadvantages of chemical synthesis, the production of D-tagatose by biotechnology has become a hot topic of research [51].
In contrast, the production of D-tagatose by biological methods is superior to chemical methods in many ways, including enzymatic conversion and whole-cell catalysis. Enzymatic conversion methods, which use enzymes as catalysts, have advantages over chemical methods because they are substrate specific and produce products without any by-products, thus simplifying the product purification process. The whole-cell method allows a wide range of bacteria to be used as whole-cell factories. In addition, D-galactitol dehydrogenase can be used to convert D-galactitol to D-tagatose. In summary, the bioprocess for D-tagatose production offers advantages such as simple steps, mild reaction conditions, safety and efficiency, high conversion efficiency, specificity, and fewer by-products [52,53]. The production of D-tagatose using biotechnological methods includes enzymatic transformation and whole-cell catalysis.

3.1. Synthesis of D-Tagatose by Enzymatic Transformation In Vitro

Enzymatic conversion is the process of using specific enzymes extracted from microorganisms, animals, and plants to catalyze the conversion of substrates into desired products under suitable conditions. Depending on the substrate and enzyme adopted, these strategies can be categorized into single-, dual-, and multi-enzyme methods.

3.1.1. Synthesis of D-Tagatose by a Single Enzyme

Currently, the single-enzyme method is the main approach for the enzymatic synthesis of D-tagatose. The types of enzymes include L-arabinose isomerase (L-AI) [47,54,55,56,57,58,59], D-tagatose 3-epimerase (DTEase) [60], D-arabinose 3-epimerase (DPEase) [61], and D-galactose dehydrogenase (GDH) [62,63] catalyzing the one-step conversion of substrates to D-tagatose. The most extensively studied method is the one-step synthesis of D-tagatose from D-galactose catalyzed by L-AI, an intracellular enzyme that is widely present in microorganisms. Patrick et al. [64] isolated L-AI from E. coli, and it was found that L-AI consists of six identical subunits with a relative molecular mass of 36,200 Da. The enzyme is composed of an N-terminal domain, a middle domain, and a C-terminal domain, and its structure includes 16 β-sheets and 17 α-helices. Within its complete hexamer, six active sites are located at the subunit–subunit interface and in the bridging region of adjacent subunits. Manjasetty [65] observed the morphology of L-AI with an electron microscope. He found that six subunits were composed of three subunits, which formed symmetrical triangles, and then the triangles were stacked into triangular prisms. There was an equivalent cleft on the surface of the triangular rhombohedron. The cleft in the subunit was located between domains, forming a strong electron density abyss, which was presumed to be the enzyme’s active center (Figure 2). L-AI catalyze not only the isomerization of L-arabinose to L-ribulose but also D-galactose to D-tagatose (Figure 3A) [66,67,68]. In 1993, Cheetham et al. [69] not only reported for the first time that L-AI from microbial sources could catalyze the isomerization of L-arabinose to L-fructose but also successfully used L-AI from Mycobacterium phlei and Lactobacillus gayonii to convert D-galactose into D-tagatose. Since then, L-AI from microbial sources has become one of the most widely studied enzymes in the research on the synthesis of D-tagatose.
Depending on the catalytic temperature, the microbial sources of L-AI can be classified as mesophilic, thermophilic, or hyperthermophilic microorganisms. The optimum reaction temperature of mesophilic microbial sources, including Lactobacillus brevis [30], Bacillus coagulans [43], Lactobacillus fermentum [70], Pediococcus pentosaceus [71], Lactobacillus plantarum [72], and E. coli [73], is 30–50 °C [25]. For thermophilic microbial sources, including Geobacillus stearothermophilus [74,75], Geobacillus thermodenitrificans [40,76], Bacillus stearothermop hilus [77,78], and Arthrobacter psychrolactophilus [79], the optimum reaction temperature is 60–80 °C. The optimum reaction temperature of L-AI from hyperthermophilic microbial sources, including Thermotoga neapolitana [41,80] and Thermotoga maritima [81,82], is 85–90 °C. The properties of L-AI from various microbial sources shown in Table 2.
The conversion of D-galactose varies depending on the monosaccharide isomerase and the conditions used. The reaction temperature is an important parameter for catalyzing the aldoketose isomerization reaction in vitro, and the isomerization equilibrium between D-galactose and D-tagatose gradually favors D-tagatose as the reaction temperature increases. Additionally, intracellular enzymes that are not involved in D-tagatose synthesis are less active under high-temperature conditions, which reduces the occurrence of side reactions and is more conducive to purification for downstream engineering [13]. The anaerobic thermophilic bacterium Thermoanaerobacterium brockii, produced and characterized in E. coli [83], produced D-tagatose from 300 g/L of D-galactose at 65 °C, with a yield of 126 g/L and a conversion rate of 42%. Kim BC et al. [56] cloned the araA gene encoding L-AI from the thermophilic bacterium Thermotoga neapolitana 5068 and expressed it in E. coli. The recombinant enzyme was purified by heat treatment, ion exchange chromatography, and gel filtration at an isomerization temperature of 80 °C, and the recombinant enzyme produced 1.22 g/L of D-tagatose from 1.8 g/L of D-galactose, with a conversion rate of 68%. The temperature exceeding 80 °C may result in undesirable Maillard reactions, which can decrease sugar production. Therefore, the temperature for D-tagatose production is usually set at 60–70 °C for industrial production, and heat-resistant enzymes are preferred.
L-AI is also affected by pH. The optimal pH of L-AI from different microbial sources varies. Most L-AI exhibits maximum activity under neutral or alkaline conditions. For instance, the araA gene encoding L-AI was cloned from the hyperthermophilic bacterium Thermotoga maritima and had maximum activity at 90 °C and pH 7.5 [81]. Chouayekh H et al. [72] cloned and expressed the gene araA encoding L-AI from Lactobacillus plantarum NC8. It exhibited 68% of its maximum activity at pH 5.5 and retained 89% of its activity after incubation at pH 5 for 24 h. The purified L-AI NC8 achieved a biotransformation rate of 30% for the conversion of D-galactose into D-tagatose after 6 h of reaction at 60 °C.
In addition, metal ions are essential cofactors of L-AI, especially Mn2+ and/or Co2+, which play an important role in the activity and stability of L-AI [43]. These metal ions bind to the active center of the enzyme and help stabilize its protein structure, enabling effective catalysis. For example, Kim JW et al. [84] cloned L-AI from the thermophilic bacterium IM6501 using the PCR method. The purified L-AI has heat resistance and exhibits the highest activity when reacted for 30 min at 60 °C and pH 8. The Zn2+ and Ni2+ deactivated the catalytic activity of L-AI, while 5 mM Mn2+ increased the biotransformation rate by 90%. Lee DW et al. [81] cloned the araA gene encoding L-AI from the hyperthermophilic bacterium Thermotoga maritima, it is more thermostable in the presence of Mn2+ and/or Co2+ than in their absence, the enzyme achieved a conversion rate of 56% for the isomerization of D-galactose into D-tagatose at 80 °C, with a reaction time of 6 h.
To improve the efficiency of producing D-tagatose with L-AI, some researchers have used immobilized enzyme methods to enhance production efficiency. Kim P et al. [87] immobilized L-AI from E. coli on agarose to produce D-tagatose. The immobilized L-AI produced an average of 7.5 g/(L·d) D-tagatose for 7 days, with a yield exceeding that of free enzymes. Using an expanded immobilized enzyme system, 99.9 g/L D-tagatose was produced within 48 h from D-galactose, with a balance of 20%. Kim H J et al. [88] immobilized L-AI Gali152 on alginate carriers and optimized the conditions for the D-galactose isomerization reaction. Under stable conditions of pH 8.0 and 60 °C, the immobilized enzyme produced 58 g/L of D-tagatose from 100 g/L of D-galactose in an intermittent reaction over 90 h. In contrast, free enzyme, due to its lower stability, produced only 37 g/L of D-tagatose. In a continuous circulation mode, Gali152 immobilized in alginate beads was used in a packed-bed bioreactor with galactose as a raw material, producing 230 g/L of D-tagatose from 500 g/L of D-galactose, with a productivity of 9.6 g/(L·h) and a conversion rate of 46%.
Despite the efficiency and simplicity of the catalytic reaction between D-galactose and L-AI, the high cost of D-galactose currently poses a challenge to its widespread industrial production. To mitigate this issue, D-lactose or whey is commonly used as a raw material in the industrial production of D-tagatose. The initial step involves the acid hydrolysis of D-lactose or whey, which converts it into a mixture of D-glucose and D-galactose. Subsequently, L-AI is utilized to convert the D-galactose into D-tagatose, resulting in a significant reduction in the cost of D-tagatose production. It was reported that Zhang et al. [13] used recombinant E. coli to express L-AI from Lactobacillus plantarum CY6. The net yield and volumetric productivity of D-tagatose after two-stage SSB were 0.7 mol/mol D-lactose and 0.54 g/(L·h), respectively. Shin KC et al. [89] identified a D-tagaturate 3-epimerase from Thermotoga petrophila, which has potential 4-epimerase activity towards D-fructose. Through genetic engineering, the enzyme was modified to enhance its 4-epimerase activity towards D-fructose. At 80 °C, the enzyme produced 213 g/L of D-tagatose from 700 g/L of D-fructose within 2 h, with a conversion rate of 30%.

3.1.2. Synthesis of D-Tagatose by Dual Enzymes

Although the single-enzyme method is relatively simple to operate and does not require complex steps and multiple enzymes, the method may be limited by various factors, such as the characteristics of the enzyme itself, the properties of the substrate, and the reaction conditions, which can affect the efficiency and accuracy of the reaction. The dual-enzyme method can optimize the disadvantages of the single-enzyme method to a certain extent, thereby improving the efficiency of producing D-tagatose. The synthesis of D-tagatose by dual-enzyme catalysis relies on D-lactose as the substrate. First, D-lactose is hydrolyzed into D-galactose by β-galactosidase. Subsequently, D-galactose is converted into D-tagatose using L-AI as the catalyst (Figure 3B). Zheng et al. [73] used a recombinant E. coli expressing L-AI to establish a one-pot biosynthesis process for D-lactose hydrolysis and D-galactose isomerization at 50 °C. Using whey permeate containing 100 g/L of D-lactose as the raw material, they produced 23.5 g/L of D-tagatose and 26.9 g/L of bioethanol, with a conversion rate of 23.5%. This process does not require the addition of extra β-galactosidase, simplifies the biotransformation process, and reduces production costs. The gatz gene from Caldilinea aerophile (a filamentous thermophilic bacterium found in Japanese hot springs) was heterologously expressed in E. coli BL21, and the purified recombinant gatz was coupled with phosphatase (PGP) to construct a two-enzyme catalytic system that transformed F6P to produce D-tagatose [90]. The gatz has the properties of 6-phosphofructose 4-isomerase with an optimum pH of 8.0, is a metal-dependent enzyme with an optimum metal ion of Mg2+, and has a high thermal stability with an optimum temperature of 70 °C. After holding at 60 °C for 30 h, it can still maintain more than 80% of the initial enzyme activity. When PGP was added together with gatz, the final yield was approximately twice that when PGP was added after the gatz reaction, yielding 1.23 g/L and 0.60 g/L of D-tagatose after 6 h, respectively. In addition, the reaction reached equilibrium at 50 and 150 min, with final yields of 4.1% and 2.0%, respectively [91]. Therefore, the consumption of 6-phosphate D-tagatose by PGP would drive the equilibrium of the gatz-catalyzed reaction towards D-tagatose production and increase the final concentration of D-tagatose.

3.1.3. Synthesis of D-Tagatose by Multi-Enzyme

In recent years, with the discovery of more enzyme preparations with novel functions, methods for synthesizing rare sugars based on multi-enzyme catalytic systems have gradually emerged. These new methods have the advantages of high efficiency, simplicity, and low cost. For the synthesis of D-tagatose, various enzyme conversion methods have been studied. Among the isomers of D-tagatose, D-fructose is the cheapest. However, there are no naturally occurring enzymes that can directly convert D-fructose into D-tagatose. While the conversion of D-fructose to D-tagatose can barely be achieved by the single-enzyme method, D-tagatose can be produced by a multi-enzyme catalytic system based on the Izumoring strategy and a phosphorylation–dephosphorylation multi-enzyme catalytic system. The Izumoring strategy was used for the biological production of all hexoses—16 aldohexoses, 8 ketohexoses, and 10 hexanols using enzymatic and microbial reactions that can cycle and prepare all monosaccharides using three enzymes (D-tagatose 3-epimerase, polyol dehydrogenases, and aldose isomerases) [92].
The phosphorylation–dephosphorylation multi-enzyme catalytic system involves a series of enzymes, starting with kinases or phosphatases, that react to produce phosphorylated sugars. Subsequently, the sugars are gradually converted using isomerase, differential isomerase, or synthase, and the phosphate groups are removed using phosphatase to obtain the target product (Figure 3C). Dai et al. [93] used this system to obtain D-tagatose by a three-step enzymatic cascade reaction involving hexokinase, D-fructose-1,6-bisphosphate aldolase (FbaA), and phytase (a phosphatase), with D-fructose as the substrate, and its conversion rate could reach 80%. Although this approach reduces the production costs of D-tagatose, the starting enzyme, kinase, requires the participation of ATP during the reaction, which is unstable at high temperatures and results in difficulty in purifying the product, making it unsuitable for practical production. In contrast, Wichelecki et al. [94] employed different functional phosphorylases as starting enzymes to synthesize high-purity D-tagatose in one step, where maltodextrin, cellulose, or sucrose were used as substrates after a multistep enzyme-catalyzed conversion. Han et al. [95] synthesized D-tagatose using starch as a substrate. This reaction pathway involves α-glucan phosphorylase (αGP), phosphoglucomutase (PGM), phosphoglucose isomerase (PGI), D-tagatose 6-phosphate 4-epimerase (TPE), and D-tagatose 6-phosphate phosphatase (T6PP), and this method further reduces the production cost of D-tagatose. Zhang et al. [96] synthesized D-tagatose from maltodextrin using a four-step enzymatic reaction. They immobilized α-glucan phosphorylase (αGP) and phosphoglucose mutase (PGM) on Duolite A568 exchange resin, constructing a catalytic cascade system to generate the D-tagatose precursor glucose 6-phosphate (G6P). The co-immobilized αGP&PGM can serve as a catalyst for one-pot production of G6P, which can serve as an initial pathway for further production of D-tagatose. Currently, over 30 phosphorylases have been explored and identified [97], which are anticipated to facilitate the one-step production of D-tagatose while reducing costs.
Figure 3. Enzymatic synthesis of D-tagatose. L-AI catalyzes D-galactose isomerization to D-tagatose (A). Lactose undergoes hydrolysis with β-galactosidase, resulting in the formation of D-galactose. The D-galactose is transformed to D-tagatose using L-AI as the catalyst (B). Fructose is converted by hexokinase into fructose-6-phosphate, which is then converted by fructose-1, 6-diphosphate into taglose-6-phosphate, which is finally catalyzed by phosphatase into D-tagatose (C).
Figure 3. Enzymatic synthesis of D-tagatose. L-AI catalyzes D-galactose isomerization to D-tagatose (A). Lactose undergoes hydrolysis with β-galactosidase, resulting in the formation of D-galactose. The D-galactose is transformed to D-tagatose using L-AI as the catalyst (B). Fructose is converted by hexokinase into fructose-6-phosphate, which is then converted by fructose-1, 6-diphosphate into taglose-6-phosphate, which is finally catalyzed by phosphatase into D-tagatose (C).
Fermentation 11 00046 g003

3.2. Whole-Cell Catalytic Synthesis of D-Tagatose

Compared with in vitro enzymatic methods, whole-cell catalysis does not require cell fragmentation or enzyme isolation and purification, and the cell membrane prevents enzyme damage by shear forces, which is conducive to improving enzyme stability and reducing production costs. In addition to the use of L-AI for in vitro catalysis, whole-cell catalysis has been extensively studied, with E. coli being one of the most commonly used hosts [98,99,100]. Figure 4 shows the construction of the metabolic pathway for the synthesis of D-tagatose in E. coli in vivo. The whole-cell catalysis of multi-enzyme co-expressing recombinant strains has the advantages of high efficiency, low cost, and good reaction stability, and has been widely used in the biosynthesis of many important chemicals [97,101,102,103]. Yuan et al. [104] demonstrated the overexpression of L-AI, which was derived from Lactobacillus parabuchneri in E. coli BL21, and the recombinant bacterium was employed to catalyze 140 g/L D-galactose to produce 54 g/L D-tagatose with a conversion efficiency of 39% and a yield of 0.54 g/(L∙h). Du et al. [105] adopted a single-factor experiment to optimize the process conditions for the cell-catalyzed production of D-tagatose by Lactobacillus brevis sp, and the yield of D-tagatose was 3.916 g/L at pH 7.0 and 55 °C for 48 h, catalyzing 9 g/L D-galactose with a conversion rate of 43.5%. It was shown that the catalytic time was 48 h when cells were used as catalysts, and the cells could be reused three times to the maximum extent. Therefore, the use of cells as catalysts in the industrial production of D-tagatose could save a lot of cost and facilitate the stable production of D-tagatose. The reaction time of L-AI as a catalyst was relatively short, at 23 h, but the conversion efficiency per unit time was relatively high. However, the process of purification of L-AI required a long time for cell wall breaking, the purification process required a lot of energy, and the yield of L-AI was lower compared with that of cell catalysis after two instances of reuse. Together, these results suggest that the cell conversion method is more suitable for the industrial production of D-tagatose. Many researchers have found that a variety of microorganisms can catalyze the production of D-galactitol to D-tagatose, including Mycobacterium smegmatis [62,68], Enterobater agglomerans [106], Klebsiella pneumoniae [107], Acetobacter [108], and Arthrobacter globiformis [109]. However, owing to the relatively high costs of D-galactose and D-galactitol, their fermentation processes as substrates are difficult to apply for industrial production.
Some research has shown that by expressing a multi-enzyme catalytic system consisting of five heat-resistant enzymes, E. coli was able to synthesize D-tagatose using maltodextrin as a substrate, with a yield of 1.88 g/L and a conversion rate of 18.8%, which was 5.9% higher than the conversion rate of the in vitro multi-enzyme catalytic system under the same experimental conditions [87]. Under optimal reaction conditions, recombinant cells were co-expressed for 24 h with 10 g/L and 20 g/L maltodextrin as substrates, yielding 2.08 g/L and 3.2 g/L D-tagatose [110]. There is a growing interest in the use of whole-cell catalysts in chemical synthesis [102,111]. The application of whole-cell catalysts can avoid the need to supplement expensive cofactors and preparation steps such as enzyme purification and isolation [112].
D-tagatose can be synthesized through two pathways: epimerization or oxidoreduction [113]. Many D-tagatose production routes involve epimerization. In the epimerization synthesis pathway, L-AI can convert D-galactose to D-tagatose. Co-expression of β-D-tagatose galactosidase and L-AI in Saccharomyces cerevisiae produces D-tagatose from D-lactose and achieves a conversion rate of 30%, which is higher than that of most in vitro enzymatic reactions [85]. D-tagatose can be produced from D-fructose through epimerization. However, although a large number of UDP-hexose 4-epimerases have been identified in various organisms, enzymes with excellent catalytic activity for the epimerization of D-fructose are rare [114,115]. Thus, D-tagatose can be produced by modifying some enzymes. In order to reduce production costs, a whole-cell biocatalytic system involving α-glucan phosphorylase, phosphoglucomutase, D-glucose 6-phosphate isomerase, D-tagatose 1,6-bisphosphate aldolase, and phosphoglycolate phosphatase was constructed to produce D-tagatose from maltodextrin [110]. However, the biotransformation efficiency of this whole-cell catalyst was low because of the unbalanced ratio of each enzyme and metabolic flux of the intermediates. By optimizing vectors and improving the expression of rate-limiting enzymes through the construction of multi-copy genes to regulate expression levels, the conversion rate of D-tagatose increased from 20.8% after 24 h to 25.2% after 3 h using 10 g/L maltodextrin as the substrate. Furthermore, the genes in the bypass pathways in E. coli, pfka and zwf, were deleted to increase the accumulation of intermediates. The strain ER-2GatZ (ΔpΔz) produced 3.383 g/L D-tagatose using 10 g/L substrate after 3 h, which was 1.34 times that of the wild strain [116]. However, due to the chemical equilibrium limitations of the epimerization reaction, epimerization was replaced by the oxidoreduction process. In the oxidoreduction pathway, D-galactose is first converted into D-galactitol, which is then converted into D-tagatose under the catalysis of galactitol-2-dehydrogenase from Rhizobium leguminosarum (GDH) and D-xylose-1-reductase isolated from S. stipites (XYL1). D-tagatose was ultimately extracted from D-lactose at 37.69 g/L [117]. With this route, although D-galactose is efficiently converted into D-tagatose without being limited by the equilibrium, further optimization is required.
Rhimi et al. [118] successfully catalyzed the production of D-tagatose and D-fructose from D-lactose hydrolysates using sodium alginate-embedded engineered bacteria co-expressing thermophilic L-AI and D-glucose isomerase. It was shown that the optimal temperature for D-galactose and D-glucose isomerization was 80 °C and 85 °C, respectively, and the activity of both isomerases was optimal at pH 7.5. The cell encapsulation significantly enhanced the acid resistance of both isomerases and their stability at a high temperature, but the isolation and purification of the sugar fractions in the mixture remained at the exploratory stage. Therefore, although whole-cell catalysis eliminates the enzyme extraction steps, the production process is simpler; however, it poses difficulties for downstream extraction due to the complexity of its fermentation products (Table 3).

4. Conclusions and Prospects

D-tagatose is a low-calorie sweetener with physiological functions, such as hypoglycemia, obesity prevention, anti-caries, and probiotics, and it is gaining popularity among consumers and is widely employed in the food and biomedical fields [24]. The production of D-tagatose by biological methods has the advantages of green environmental protection, safety, and efficiency, and it can be achieved by in vitro enzymes and whole-cell catalysis using D-galactose as substrates. However, D-galactose has a high cost, and traditional manufacturing methods can only convert about 30% of D-galactose, with the additional high cost of separating D-tagatose, leading to a persistently high retail price for D-tagatose. The development of synthetic biology and other technologies has brought more solutions to the future production of D-tagatose, such as using inexpensive substrates like D-fructose, D-lactose, maltodextrin, and starch as raw materials to reduce production costs. A multi-enzyme catalytic system based on the Izumoring strategy and a phosphorylation–dephosphorylation multi-enzyme catalytic system has been shown to produce D-tagatose using fructose as a substrate. Although in vitro multi-enzyme catalytic systems simplify the biotransformation process and reduce production costs, they are susceptible to interference from external conditions, and product isolation and purification can be challenging. An alternative approach for industrial production is the whole-cell catalytic method, which involves the construction of a de novo D-tagatose synthesis pathway in E. coli and other cells to catalyze the synthesis of D-fructose or D-lactose into D-tagatose. This method offers high conversion rates and a stable production process, and does not require additional ATP. Overall, the whole-cell catalytic method is the most promising approach for the industrial production of D-tagatose.
By optimizing the whole-cell catalytic conditions and strengthening the conversion system, safe and efficient production of D-tagatose was achieved, laying a good research foundation for the industrial production of D-tagatose. Various efforts have been made to reduce the cost of D-tagatose production by using inexpensive raw materials as substrates; however, there are still some shortcomings at the current stage of research. For example, the enzyme has poor thermal stability, poor substrate specificity, low catalytic efficiency, and other shortcomings. In subsequent research, the protein’s crystal structure has been analyzed and resolved by combining it with molecular simulation tools, and the target protein was modified using directed evolution and rational design methods to obtain a recombinant enzyme with stronger substrate specificity and catalytic conditions that meet the requirements of industrial production. The popular host in D-tagatose production is E. coli. However, the use of E. coli, a conditional pathogenic bacterium, as a host for producing D-tagatose, a functional food additive, is controversial. From the perspective of food safety, subsequent experiments should select food-safe strains or adopt extracellular expression and other means to realize the function of D-tagatose synthesis so that the safety of the whole-cell D-tagatose catalyst meets the requirements of industrial food production.
Fortunately, the development of synthetic biology and other technologies has brought more solutions to the future production of D-tagatose [121]. Currently, there are mainly three approaches to attempt to expand the production capacity of D-tagatose. Some companies, like Roquette and Bonumose, use starch as a raw material to produce D-tagatose on a large scale through enzymatic conversion processes. Another approach involves utilizing genetic engineering and synthetic biology technologies to produce D-tagatose on a large scale through yeast-based fermentation [113]. The third approach employs bacteria such as E. coli as miniature bioreactors that encapsulate enzymes and reactants, using substrates like maltodextrin to produce D-tagatose. We believe that with the continuous development of synthetic biology and enzyme engineering technology, the technology of producing D-tagatose by biological methods will become more mature. By optimizing enzyme preparations, improving conversion rates, and reducing energy consumption, the production of D-tagatose by biological methods will be safer and more efficient, and the cost will gradually decrease, thereby enhancing its market competitiveness.

Author Contributions

All authors contributed to the paper conception and design. H.Z. and J.L. prepared the complete draft of the manuscript and was the major contributor. X.M. and Z.L. provided the necessary information for the article and partially wrote the article. C.G. and Z.C. conceptualized, corrected, and finalized the manuscript, and supervised the work. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (NSFC) Youth Project (22408145) and the Innovation Project for Major Application Technology in the Agricultural Sector in Shandong Province (grant No. SD2019ZZ005).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study.

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. Xu, Y.; Wu, Y.; Liu, Y.; Li, J.; Du, G.; Chen, J.; Liu, L. Sustainable bioproduction of natural sugar substitutes: Strategies and challenges. Trends Food Sci. Technol. 2022, 129, 512–527. [Google Scholar] [CrossRef]
  2. Evbuomwan, S.A. Sugar Substitutes/Artificial Sweeteners: Benefits Vs Health Issues, and Alternatives. World News Nat. Sci. 2023, 50, 86–97. [Google Scholar]
  3. Arshad, S.; Rehman, T.; Saif, S.; Rajoka, M.S.; Ranjha, M.M.; Hassoun, A.; Cropotova, J.; Trif, M.; Younas, A.; Aadil, R.M. Replacement of refined sugar by natural sweeteners: Focus on potential health benefits. Heliyon 2022, 8, e10711. [Google Scholar] [CrossRef] [PubMed]
  4. Lei, P.; Chen, H.; Ma, J.; Fang, Y.; Qu, L.; Yang, Q.; Sun, D. Research progress on extraction technology and biomedical function of natural sugar substitutes. Front. Nutr. 2022, 9, 952147. [Google Scholar] [CrossRef] [PubMed]
  5. Bober, J.R.; Nair, N.U. Galactose to tagatose isomerization at moderate temperatures with high conversion and productivity. Nat. Commun. 2019, 10, 4548. [Google Scholar] [CrossRef] [PubMed]
  6. Liang, M.; Chen, M.; Liu, X.; Zhai, Y.; Liu, X.W.; Zhang, H.; Xiao, M.; Wang, P. Bioconversion of D-galactose to D-tagatose: Continuous packed bed reaction with an immobilized thermostable L-arabinose isomerase and efficient purification by selective microbial degradation. Appl. Microbiol. Biotechnol. 2012, 93, 1469–1474. [Google Scholar] [CrossRef]
  7. Sylvetsky, A.C.; Jin, Y.; Clark, E.J.; Welsh, J.A.; Rother, K.I.; Talegawkar, S.A. Consumption of low-calorie sweeteners among children and adults in the United States. J. Acad. Nutr. Diet. 2017, 117, 441–448. [Google Scholar] [CrossRef]
  8. Sylvetsky, A.C.; Rother, K.I. Trends in the consumption of low-calorie sweeteners. Physiol. Behav. 2016, 164, 446–450. [Google Scholar] [CrossRef]
  9. Tandel, K.R. Sugar substitutes: Health controversy over perceived benefits. J. Pharmacol. Pharmacother. 2011, 2, 236–243. [Google Scholar] [CrossRef] [PubMed]
  10. Singh, P.; Ban, Y.G.; Kashyap, L.; Siraree, A.; Singh, J. Sugar and sugar substitutes: Recent developments and future prospects. In Sugar and Sugar Derivatives: Changing Consumer Preferences; Springer: Singapore, 2020; pp. 39–75. [Google Scholar]
  11. Muñoz-Labrador, A.; Hernandez-Hernandez, O.; Moreno, F.J. A review of the state of sweeteners science: The natural versus artificial non-caloric sweeteners debate. Stevia rebaudiana and Siraitia grosvenorii into the spotlight. Crit. Rev. Biotechnol. 2024, 44, 1080–1102. [Google Scholar]
  12. Hu, M.; Li, M.; Jiang, B.; Zhang, T. Bioproduction of D-allulose: Properties, applications, purification, and future perspective. Compr. Rev. Food Sci. Food Saf. 2021, 20, 6012–6026. [Google Scholar] [CrossRef]
  13. Zhang, G.Y.; Zabed, H.M.; Yun, J.H.; Yuan, J.; Zhang, Y.F.; Wang, Y.; Qi, X.H. Two-stage biosynthesis of D-tagatose from milk whey powder by an engineered Escherichia coli strain expressing L-arabinose isomerase from Lactobacillus plantarum. Bioresour. Technol. 2020, 305, 123010. [Google Scholar] [CrossRef] [PubMed]
  14. Assadi-Porter, F.M.; Aceti, D.J.; Cheng, H.; Markley, J.L. Efficient production of recombinant brazzein, a small, heat-stable, sweet-tasting protein of plant origin. Arch. Biochem. Biophys. 2000, 376, 252–258. [Google Scholar] [CrossRef] [PubMed]
  15. Mahajan, M.; Naveen, P.; Pal, P.K. Agronomical and biotechnological strategies for modulating biosynthesis of steviol glycosides of Stevia rebaudiana Bertoni. J. Appl. Res. Med. Aromat. Plants 2024, 43, 100580. [Google Scholar] [CrossRef]
  16. Zhang, W.; Yu, S.; Zhang, T.; Jiang, B.; Mu, W. Recent advances in D-allulose: Physiological functionalities, applications, and biological production. Trends Food Sci. Technol. 2016, 54, 127–137. [Google Scholar] [CrossRef]
  17. Chung, J.H.; Kong, J.N.; Choi, H.E.; Kong, K.H. Antioxidant, anti-inflammatory, and anti-allergic activities of the sweet-tasting protein brazzein. Food Chem. 2018, 267, 163–169. [Google Scholar] [CrossRef] [PubMed]
  18. Karabinos, J.V. Psicose, sorbose and tagatose. Adv. Carbohydr. Chem. 1952, 7, 99–136. [Google Scholar] [PubMed]
  19. Adachi, S. Formation of lactulose and tagatose from lactose in strongly heated milk. Nature 1958, 181, 840–841. [Google Scholar] [CrossRef]
  20. Miao, P.; Wang, Q.; Ren, K.; Zhang, Z.; Xu, T.; Xu, M.; Rao, Z. Advances and Prospects of d-Tagatose Production Based on a Biocatalytic Isomerization Pathway. Catalysts 2023, 13, 1437. [Google Scholar] [CrossRef]
  21. Mayumi, S.; Kuboniwa, M.; Sakanaka, A.; Hashino, E.; Ishikawa, A.; Ijima, Y.; Amano, A. Potential of prebiotic D-tagatose for prevention of oral disease. Front. Cell. Infect. Microbiol. 2021, 11, 767944. [Google Scholar] [CrossRef]
  22. Donner, T.W.; Magder, L.S.; Zarbalian, K. Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol. Nutr. Res. 2010, 30, 801–806. [Google Scholar] [CrossRef] [PubMed]
  23. Ravikumar, Y.; Ponpandian, L.N.; Zhang, G.; Yun, J.; Qi, X. Harnessing L-arabinose isomerase for biological production of D-tagatose: Recent advances and its applications. Trends Food Sci. Tech. 2021, 107, 16–30. [Google Scholar] [CrossRef]
  24. Ortiz, A.D.; Fideles, S.O.; Reis, C.H.; Pagani, B.T.; Bueno, L.M.; Moscatel, M.B.; Buchaim, R.L.; Buchaim, D.V. D-Tagatose: A Rare Sugar with Functional Properties and Antimicrobial Potential against Oral Species. Nutrients 2024, 16, 1943. [Google Scholar] [CrossRef] [PubMed]
  25. Patel, M.J.; Patel, A.T.; Akhani, R.; Dedania, S.; Patel, D.H. Bioproduction of D-tagatose from D-galactose using phosphoglucose isomerase from Pseudomonas aeruginosa PAO1. Appl. Biochem. Biotech. 2016, 179, 715–727. [Google Scholar] [CrossRef] [PubMed]
  26. Roy, S.; Chikkerur, J.; Roy, S.C.; Dhali, A.; Kolte, A.P.; Sridhar, M.; Samanta, A.K. Tagatose as a potential nutraceutical: Production, properties, biological roles, and applications. J. Food Sci. 2018, 83, 2699–2709. [Google Scholar] [CrossRef]
  27. Venema, K.; Vermunt, S.H.F.; Brink, E.J. D-Tagatose increases butyrate production by the colonic microbiota in healthy men and women. Microb. Ecol. Health Dis. 2005, 17, 47–57. [Google Scholar]
  28. Kim, B.J.; Hong, S.H.; Shin, K.C.; Jo, Y.S.; Oh, D.K. Characterization of a F280N variant of l-arabinose isomerase from Geobacillus thermodenitrificans identified as a d-galactose isomerase. Appl. Microbiol. Biotechnol. 2014, 98, 9271–9281. [Google Scholar] [CrossRef] [PubMed]
  29. Donner, T.W.; Wilber, J.F.; Ostrowski, D. D-tagatose, a novel hexose: Acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes. Diabetes Obes. Metab. 1999, 1, 285–291. [Google Scholar] [CrossRef] [PubMed]
  30. Guo, Q.; An, Y.; Yun, J.; Yang, M.; Magocha, T.A.; Zhu, J.; Qi, X. Enhanced D-tagatose production by spore surface-displayed L-arabinose isomerase from isolated Lactobacillus brevis PC16 and biotransformation. Bioresour. Technol. 2018, 247, 940–946. [Google Scholar] [CrossRef]
  31. Levin, G.V. Tagatose, the new GRAS sweetener and health product. J. Med. Food 2002, 5, 23–36. [Google Scholar] [CrossRef] [PubMed]
  32. Saunders, J.P.; Donner, T.W.; Sadler, J.H.; Levin, G.V.; Makris, N.G. Effects of acute and repeated oral doses of D-tagatose on plasma uric acid in normal and diabetic humans. Regul. Toxicol. Pharm. 1999, 29, S57–S65. [Google Scholar] [CrossRef] [PubMed]
  33. Kruger, C.L.; Whittaker, M.H.; Frankos, V.H.; Trimmer, G.W. 90-day oral toxicity study of d-tagatose in rats. Regul. Toxicol. Pharm. 1999, 29, S1–S10. [Google Scholar] [CrossRef] [PubMed]
  34. Levin, G.V.; Zehner, L.R.; Saunders, J.P.; Beadle, J.R. Sugar substitutes: Their energy values, bulk characteristics, and potential health benefits. Am. J. Clin. Nutr. 1995, 62, 1161S–1168S. [Google Scholar] [CrossRef] [PubMed]
  35. Wong, D. Sweetener determined safe in drugs, mouthwashes, and toothpastes. Dent. Today 2000, 19, 32–34. [Google Scholar]
  36. Yu, P.L.; Limsowtin, G.K.; Crow, V.L.; Pearce, L.E. In vivo and in vitro expression of a Streptococcus lactis tagatose 1, 6-bisphosphate aldolase gene in Escherichia coli. Appl. Microbiol. Biotechnol. 1988, 28, 471–473. [Google Scholar] [CrossRef]
  37. Bertelsen, H.; Andersen, H.; Tvede, M. Fermentation of D-tagatose by human intestinal bacteria and dairy lactic acid bacteria. Microb. Ecol. Health Dis. 2001, 13, 87–95. [Google Scholar] [CrossRef]
  38. Patra, F.; Tomar, S.K.; Arora, S. Technological and functional applications of low-calorie sweeteners from lactic acid bacteria. J. Food Sci. 2009, 74, R16–R23. [Google Scholar] [CrossRef] [PubMed]
  39. Deok, K.O. Tagatose: Properties, applications, and biotechnological processes. Appl. Microbiol. Biotechnol. 2007, 76, 1–8. [Google Scholar]
  40. Jayamuthunagai, J.; Gautam, P.; Srisowmeya, G.; Chakravarthy, M. Biocatalytic production of D-tagatose: A potential rare sugar with versatile applications. Crit. Rev. Food Sci. Nutr. 2017, 57, 3430–3437. [Google Scholar] [CrossRef]
  41. Bertelsen, H.; Jensen, B.B.; Buemann, B. D-Tagatose-a novel low-calorie bulk sweetener with prebiotic properties. Low-Calor. Sweeten. Present. Future 1999, 85, 98–109. [Google Scholar]
  42. Chahed, A.; Nesler, A.; Aziz, A. A review of knowledge on the mechanisms of action of the rare sugar d-tagatose against phytopathogenic oomycetes. Plant Pathol. 2021, 70, 1979–1986. [Google Scholar] [CrossRef]
  43. Mei, W.; Wang, L.; Zang, Y.; Zheng, Z.; Ouyang, J. Characterization of an L-arabinose isomerase from Bacillus coagulans NL01 and its application for D-tagatose production. BMC Biotechnol. 2016, 16, 55. [Google Scholar] [CrossRef]
  44. Torres, P.; Batista-Viera, F. Immobilized trienzymatic system with enhanced stabilization for the biotransformation of lactose. Molecules 2017, 22, 284. [Google Scholar] [CrossRef] [PubMed]
  45. Zhao, J.; Wang, Z.; Jin, Q.; Feng, D.; Lee, J. Isomerization of galactose to tagatose: Recent advances in non-enzymatic isomerization. J. Agric. Food Chem. 2023, 71, 4228–4234. [Google Scholar] [CrossRef] [PubMed]
  46. Drabo, P.; Delidovich, I. Catalytic isomerization of galactose into tagatose in the presence of bases and Lewis acids. Catal. Commun. 2018, 107, 24–28. [Google Scholar] [CrossRef]
  47. Kim, P. Current studies on biological tagatose production using L-arabinose isomerase: A review and future perspective. Appl. Microbiol. Biotechnol. 2004, 65, 243–249. [Google Scholar] [CrossRef]
  48. Gao, D.M.; Kobayashi, T.; Adachi, S. Production of rare sugars from common sugars in subcritical aqueous ethanol. Food Chem. 2015, 175, 465–470. [Google Scholar] [CrossRef]
  49. Milasing, N.; Khuwijitjaru, P.; Adachi, S. Isomerization of galactose to tagatose using arginine as a green catalyst. Food Chem. 2023, 398, 133858. [Google Scholar] [CrossRef] [PubMed]
  50. Murzin, D.Y.; Murzina, E.V.; Aho, A.; Kazakova, M.A.; Selyutin, A.G.; Kubicka, D.; Kuznetsov, V.L.; Simakova, I.L. Aldose to ketose interconversion: Galactose and arabinose isomerization over heterogeneous catalysts. Catal. Sci. Technol. 2017, 7, 5321–5331. [Google Scholar] [CrossRef]
  51. Zhang, H.; Yun, J.; Zabed, H.; Yang, M.; Zhang, G.; Qi, Y.; Qi, X. Production of xylitol by expressing xylitol dehydrogenase and alcohol dehydrogenase from Gluconobacter thailandicus and co-biotransformation of whole cells. Bioresour. Technol. 2018, 257, 223–228. [Google Scholar] [CrossRef] [PubMed]
  52. Lu, Y. Humectancies of d-tagatose and d-sorbitol. Int. J. Cosmet. Sci. 2001, 23, 175–181. [Google Scholar] [CrossRef] [PubMed]
  53. Helanto, M.; Kiviharju, K.; Leisola, M.; Nyyssölä, A. Metabolic engineering of Lactobacillus plantarum for production of L-ribulose. Appl. Environ. Microbiol. 2007, 73, 7083–7091. [Google Scholar] [CrossRef] [PubMed]
  54. Yoon, S.H.; Kim, P.; Oh, D.K. Properties of L-arabinose isomerase from Escherichia coli as biocatalyst for tagatose production. World J. Microb. Biot. 2003, 19, 47–51. [Google Scholar] [CrossRef]
  55. Lim, B.C.; Kim, H.J.; Oh, D.K. High production of D-tagatose by the addition of boric acid. Biotechnol. Progr. 2007, 23, 824–828. [Google Scholar] [CrossRef]
  56. Kim, B.C.; Lee, Y.H.; Lee, H.S.; Lee, D.W.; Choe, E.A.; Pyun, Y.R. Cloning, expression and characterization of L-arabinose isomerase from Thermotoga neapolitana: Bioconversion of D-galactose to D-tagatose using the enzyme. FEMS Microbiol. Lett. 2002, 212, 121–126. [Google Scholar] [PubMed]
  57. Rhimi, M.; Bejar, S. Cloning, purification and biochemical characterization of metallic-ions independent and thermoactive L-arabinose isomerase from the Bacillus stearothermophilus US100 strain. BBA-Gen. Subj. 2006, 1760, 191–199. [Google Scholar] [CrossRef] [PubMed]
  58. Cheng, L.; Mu, W.; Zhang, T.; Jiang, B. An L-arabinose isomerase from Acidothermus cellulolytics ATCC 43068: Cloning, expression, purification, and characterization. Appl. Microbiol. Biotechnol. 2010, 86, 1089–1097. [Google Scholar] [CrossRef]
  59. Zhang, H.; Jiang, B.; Pan, B. Purification and characterization of L-arabinose isomerase from Lactobacillus plantarum producing D-tagatose. World J. Microb. Biot. 2007, 23, 641–646. [Google Scholar] [CrossRef]
  60. Li, S.; Chen, Z.; Zhang, W.; Guang, C.; Mu, W. Characterization of a D-tagatose 3-epimerase from Caballeronia fortuita and its application in rare sugar production. Int. J. Biol. Macromol. 2019, 138, 536–545. [Google Scholar] [CrossRef]
  61. Kim, H.J.; Hyun, E.K.; Kim, Y.S.; Lee, Y.J.; Oh, D.K. Characterization of an Agrobacterium tumefaciens D-psicose 3-epimerase that converts D-fructose to D-psicose. Appl. Environ. Microbiol. 2006, 72, 981–985. [Google Scholar] [CrossRef]
  62. Jagtap, S.S.; Singh, R.; Kang, Y.C.; Zhao, H.; Lee, J.K. Cloning and characterization of a galactitol 2-dehydrogenase from Rhizobium legumenosarum and its application in D-tagatose production. Enzym. Microb. Technol. 2014, 58, 44–51. [Google Scholar] [CrossRef] [PubMed]
  63. Izumori, K.; Miyoshi, T.; Tokuda, S.; Yamabe, K. Production of D-tagatose from dulcitol by Arthrobacter globiformis. Appl. Environ. Microbiol. 1984, 48, 1055–1057. [Google Scholar] [CrossRef] [PubMed]
  64. Patrick, J.W.; Lee, N. Subunit structure of L-arabinose isomerase from Escherichia coli. J. Biol. Chem. 1969, 244, 4277–4283. [Google Scholar] [CrossRef]
  65. Manjasetty, B.A.; Chance, M.R. Crystal structure of Escherichia coli L-arabinose isomerase(ECAI), the pu-tative target of biological tagatose production. J. Mol. Biol. 2006, 360, 297–309. [Google Scholar] [CrossRef] [PubMed]
  66. Kim, H.J.; Oh, D.K. Purification and characterization of an L-arabinose isomerase from an isolated strain of Geobacillus thermodenitrificans producing D-tagatose. J. Biotechnol. 2005, 120, 162–173. [Google Scholar] [CrossRef]
  67. Heath, E.C.; Horecker, B.L.; Smyrniotis, P.Z.; Takagi, Y. Pentose fermentation by Lactobacillus plantarum: II. L-arabinose isomerase. J. Biol. Chem. 1958, 231, 1031–1037. [Google Scholar] [CrossRef]
  68. Izumori, K.; Ueda, Y.O.; Yamanaka, K. Pentose metabolism in Mycobacterium smegmatis: Comparison of L-arabinose isomerases induced by L-arabinose and D-galactose. J. Bacteriol. 1978, 133, 413–414. [Google Scholar] [CrossRef]
  69. Cheetham, P.S.J.; Wootton, A.N. Bioconversion of D-galactose into D-tagatose. Enzym. Microb. Technol. 1993, 15, 105–108. [Google Scholar] [CrossRef]
  70. Xu, Z.; Qing, Y.; Li, S.; Feng, X.; Xu, H.; Ouyang, P. A novel L-arabinose isomerase from Lactobacillus fermentum CGMCC2921 for D-tagatose production: Gene cloning, purification and characterization. J. Mol. Catal. B-Enzym. 2011, 70, 1–7. [Google Scholar] [CrossRef]
  71. Men, Y.; Zhu, Y.; Zhang, L.; Kang, Z.; Izumori, K.; Sun, Y.; Ma, Y. Enzymatic conversion of D-galactose to D-tagatose: Cloning, over expression and characterization of L-arabinose isomerase from Pediococcus pentosaceus PC-5. Microbiol. Res. 2014, 169, 171–178. [Google Scholar] [CrossRef] [PubMed]
  72. Chouayekh, H.; Bejar, W.; Rhimi, M.; Jelleli, K.; Mseddi, M.; Bejar, S. Characterization of an L-arabinose isomerase from the Lactobacillus plantarum NC8 strain showing pronounced stability at acidic pH. FEMS Microbiol. Lett. 2007, 277, 260–267. [Google Scholar] [CrossRef]
  73. Zheng, Z.; Xie, J.; Liu, P.; Li, X.; Ouyang, J. Elegant and efficient biotransformation for dual production of D-tagatose and bioethanol from cheese whey powder. J. Agric. Food Chem. 2019, 67, 829–835. [Google Scholar] [CrossRef] [PubMed]
  74. Laksmi, F.A.; Arai, S.; Tsurumaru, H.; Nakamura, Y.; Saksono, B.; Tokunaga, M.; Ishibashi, M. Improved substrate specificity for D-galactose of L-arabinose isomerase for industrial application. Biochim. Biophys. Acta-Proteins Proteom. 2018, 1866, 1084–1091. [Google Scholar] [CrossRef]
  75. Laksmi, F.A.; Arai, S.; Arakawa, T.; Tsurumaru, H.; Nakamura, Y.; Saksono, B.; Ishibashi, M. Expression and characterization of l-arabinose isomerase from Geobacillus stearothermophilus for improved activity under acidic condition. Protein Expr. Purif. 2020, 175, 105692. [Google Scholar] [CrossRef]
  76. Shin, K.C.; Sim, D.H.; Seo, M.J.; Oh, D.K. Increased production of food-grade d-tagatose from d-galactose by permeabilized and immobilized cells of Corynebacterium glutamicum, a GRAS host, expressing d-galactose isomerase from Geobacillus thermodenitrificans. J. Agric. Food Chem. 2016, 64, 8146–8153. [Google Scholar] [CrossRef] [PubMed]
  77. Cheng, L.; Mu, W.; Jiang, B. Thermostable L-arabinose isomerase from Bacillus stearothermophilus IAM 11001 for D-tagatose production: Gene cloning, purification and characterisation. J. Sci. Food Agric. 2010, 90, 1327–1333. [Google Scholar] [CrossRef] [PubMed]
  78. Rhimi, M.; Aghajari, N.; Juy, M.; Chouayekh, H.; Maguin, E.; Haser, R.; Bejar, S. Rational design of Bacillus stearothermophilus US100 L-arabinose isomerase: Potential applications for D-tagatose production. Biochimie 2009, 91, 650–653. [Google Scholar] [CrossRef] [PubMed]
  79. Nirwantono, R.; Laksmi, F.A.; Nuryana, I.; Firdausa, S.; Herawan, D.; Giyandini, R.; Hidayat, A.A. Exploring an l-arabinose isomerase from cryophile bacteria Arthrobacter psychrolactophilus B7 for d-tagatose production. Int. J. Biol. Macromol. 2024, 254, 127781. [Google Scholar] [CrossRef]
  80. Lim, B.C.; Kim, H.J.; Oh, D.K. Tagatose production with pH control in a stirred tank reactor containing immobilized L-arabinose isomerase from Thermotoga neapolitana. Appl. Biochem. Biotechnol. 2008, 149, 245–253. [Google Scholar] [CrossRef]
  81. Lee, D.W.; Jang, H.J.; Choe, E.A.; Kim, B.C.; Lee, S.J.; Kim, S.B.; Pyun, Y.R. Characterization of a thermostable L-arabinose (D-galactose) isomerase from the hyperthermophilic eubacterium Thermotoga maritima. Appl. Environ. Microbiol. 2004, 70, 1397–1404. [Google Scholar] [CrossRef] [PubMed]
  82. Bortone, N.; Fidaleo, M. Stabilization of immobilized l-arabinose isomerase for the production of d-tagatose from d-galactose. Biotechnol. Prog. 2020, 36, e3033. [Google Scholar] [CrossRef] [PubMed]
  83. Jørgensen, F.; Hansen, O.C.; Stougaard, P. Enzymatic conversion of D-galactose to D-tagatose: Heterologous expression and characterisation of a thermostable L-arabinose isomerase from Thermoanaerobacter mathranii. Appl. Microbiol. Biotechnol. 2004, 64, 816–822. [Google Scholar] [CrossRef]
  84. Kim, J.W.; Kim, Y.W.; Roh, H.J.; Kim, H.Y.; Cha, J.H.; Park, K.H.; Park, C.S. Production of tagatose by a recombinant thermostable L-arabinose isomerase from Thermus sp. IM6501. Biotechnol. Lett. 2003, 25, 963–967. [Google Scholar] [CrossRef] [PubMed]
  85. Wanarska, M.; Kur, J. A method for the production of D-tagatose using a recombinant Pichia pastoris strain secreting beta-D-galactosidase from Arthrobacter chlorophenolicus and a recombinant L-arabinose isomerase from Arthrobacter sp. 22c. Microb. Cell Fact. 2012, 11, 113. [Google Scholar] [CrossRef] [PubMed]
  86. Nguyen, T.K.; Hong, M.G.; Chang, P.S.; Lee, B.H.; Yoo, S.H. Biochemical properties of L-arabinose isomerase from Clostridium hylemonae to produce D-tagatose as a functional sweetener. PLoS ONE 2018, 13, e0196099. [Google Scholar] [CrossRef] [PubMed]
  87. Kim, P.; Yoon, S.H.; Roh, H.J.; Choi, J.H. High production of d-tagatose, a potential sugar substitute, using immobilized l-arabinose isomerase. Biotechnol. Progr. 2001, 17, 208–210. [Google Scholar] [CrossRef] [PubMed]
  88. Kim, H.J.; Ryu, S.A.; Kim, P.; Oh, D.K. A feasible enzymatic process for d-tagatose production by an immobilized thermostable l-arabinose isomerase in a packed-bed bioreactor. Biotechnol. Progr. 2003, 19, 400–404. [Google Scholar] [CrossRef] [PubMed]
  89. Shin, K.C.; Lee, T.E.; Seo, M.J.; Kim, D.W.; Kang, L.W.; Oh, D.K. Development of tagaturonate 3-epimerase into tagatose 4-epimerase with a biocatalytic route from fructose to tagatose. ACS Catal. 2020, 10, 12212–12222. [Google Scholar] [CrossRef]
  90. Freimund, S.; Huwig, A.; Giffhorn, F.; Köpper, S. Convenient chemo-enzymatic synthesis of D-tagatose. J. Carbohydr. Chem. 1996, 15, 115–120. [Google Scholar] [CrossRef]
  91. Dai, Y.; Zhang, J.; Zhang, T.; Chen, J.; Hassanin, H.A.; Jiang, B. Characteristics of a fructose 6-phosphate 4-epimerase from Caldilinea aerophila DSM 14535 and its application for biosynthesis of tagatose. Enzym. Microb. Technol. 2020, 139, 109594. [Google Scholar] [CrossRef]
  92. Izumori, K. Izumoring: A strategy for bioproduction of all hexoses. J. Biotechnol. 2006, 124, 717–722. [Google Scholar] [CrossRef] [PubMed]
  93. Lee, S.H.; Hong, S.H.; Kim, K.R.; Oh, D.K. High-yield production of pure tagatose from fructose by a three-step enzymatic cascade reaction. Biotechnol. Lett. 2017, 39, 1141–1148. [Google Scholar] [CrossRef]
  94. Wichelecki, D.J.; Zhang, Y. Enzymatic Synthesis of D-Tagatose. U.S. Patent 20180216146A1, 2 August 2018. [Google Scholar]
  95. Han, P.; Wang, X.; Li, Y.; Wu, H.; Shi, T.; Shi, J. Synthesis of a healthy sweetener D-tagatose from starch catalyzed by semiartificial cell factories. J. Agric. Food Chem. 2023, 71, 3813–3820. [Google Scholar] [CrossRef] [PubMed]
  96. Zhang, J.; Dai, Y.; Jiang, B.; Zhang, T.; Chen, J. Dual-enzyme co-immobilization for the one-pot production of glucose 6-phosphate from maltodextrin. Biochem. Eng. J. 2020, 161, 107654. [Google Scholar] [CrossRef]
  97. Liu, Q.; Ma, X.; Cheng, H.; Xu, N.; Liu, J.; Ma, Y. Co-expression of L-glutamate oxidase and catalase in Escherichia coli to produce α-ketoglutaric acid by whole-cell biocatalyst. Biotechnol. Lett. 2017, 39, 913–919. [Google Scholar] [CrossRef] [PubMed]
  98. Lv, X.; Xu, H.; Yu, H. Significantly enhanced production of isoprene by ordered coexpression of genes dxs, dxr, and idi in Escherichia coli. Appl. Microbiol. Biotechnol. 2013, 97, 2357–2365. [Google Scholar] [CrossRef]
  99. Hou, Y.; Gao, B.; Cui, J.; Tan, Z.; Qiao, C.; Jia, S. Combination of multi-enzyme expression fine-tuning and co-substrates addition improves phenyllactic acid production with an Escherichia coli whole-cell biocatalyst. Bioresour. Technol. 2019, 287, 121423. [Google Scholar] [CrossRef]
  100. Liu, Q.; Zhou, J.; Yang, T.; Zhang, X.; Xu, M.; Rao, Z. Efficient biosynthesis of L-phenylglycine by an engineered Escherichia coli with a tunable multi-enzyme-coordinate expression system. Appl. Microbiol. Biotechnol. 2018, 102, 2129–2141. [Google Scholar] [CrossRef] [PubMed]
  101. Ošlaj, M.; Cluzeau, J.; Orkić, D.; Kopitar, G.; Mrak, P.; Časar, Z. A highly productive, whole-cell DERA chemoenzymatic process for production of key lactonized side-chain intermediates in statin synthesis. PLoS ONE 2013, 8, e62250. [Google Scholar] [CrossRef]
  102. Song, Y.; Li, J.; Shin, H.D.; Du, G.; Liu, L.; Chen, J. One-step biosynthesis of α-ketoisocaproate from l-leucine by an Escherichia coli whole-cell biocatalyst expressing an l-amino acid deaminase from Proteus vulgaris. Sci. Rep. 2015, 5, 12614. [Google Scholar] [CrossRef]
  103. Zhang, G.; Zabed, H.M.; An, Y.; Yun, J.; Huang, J.; Zhang, Y.; Qi, X. Biocatalytic conversion of a lactose-rich dairy waste into D-tagatose, D-arabitol and galactitol using sequential whole cell and fermentation technologies. Bioresour. Technol. 2022, 358, 127422. [Google Scholar] [CrossRef]
  104. Yuan, J.; Ravikumar, Y.; Zhang, G.; Yun, J.; Zhang, Y.; Zabed, H.M.; Qi, X. L-arabinose isomerase from Lactobacillus parabuchneri and its whole cell biocatalytic application in D-tagatose biosynthesis from D-galactose. Food Bios. 2021, 41, 101034. [Google Scholar] [CrossRef]
  105. Du, M.; Zhao, D.; Cheng, S.; Sun, D.; Chen, M.; Gao, Z.; Zhang, C. Towards efficient enzymatic conversion of D-galactose to D-tagatose: Purification and characterization of L-arabinose isomerase from Lactobacillus brevis. Bioprocess Biosyst. Eng. 2019, 42, 107–116. [Google Scholar] [CrossRef]
  106. Muniruzzaman, S.; Tokunaga, H.; Izumori, K. Isolation of Enterobacter agglomerans strain 221e from soil, a potent D-tagatose producer from galactitol. J. Ferment. Bioeng. 1994, 78, 145–148. [Google Scholar] [CrossRef]
  107. Shimonishi, T.; Okumura, Y.; Izumori, K. Production of L-tagatose from galactitol by Klebsiella pneumoniae strain 40b. J. Ferment. Bioeng. 1995, 79, 620–622. [Google Scholar] [CrossRef]
  108. Sudto, C.; Moonmangmee, D.; Moonmangmee, S.; Adachi, O.; Matsushita, K. Production of D-tagatose, a novel low calories sweetener by a new acetic acid bacterium, Asaia bogorensis NRIC 0311T. Biochem. Eng. 2012, 76, 60–69. [Google Scholar]
  109. Jayaraman, J.; Gautam, P. Evaluation of production & kinetics parameters of rare sugar (D-tagatose) using biocatalyst Arthrobacter globiformis. Manag. Environ. Qual. 2016, 27, 71–78. [Google Scholar]
  110. Dai, Y.; Li, M.; Jiang, B.; Zhang, T.; Chen, J. Whole-cell biosynthesis of d-tagatose from maltodextrin by engineered Escherichia coli with multi-enzyme co-expression system. Enzym. Microb. Technol. 2021, 145, 109747. [Google Scholar] [CrossRef] [PubMed]
  111. Li, Y.; Liu, S.; You, C. Permeabilized Escherichia coli Whole Cells Containing Co-Expressed Two Thermophilic Enzymes Facilitate the Synthesis of Scyllo-Inositol from Myo-Inositol. Biotechnol. J. 2020, 15, 1900191. [Google Scholar] [CrossRef]
  112. Yang, J.; Zhang, T.; Tian, C.; Zhu, Y.; Zeng, Y.; Men, Y.; Ma, Y. Multi-enzyme systems and recombinant cells for synthesis of valuable saccharides: Advances and perspectives. Biotechnol. Adv. 2019, 37, 107406. [Google Scholar] [CrossRef] [PubMed]
  113. Li, J.; Li, H.; Liu, H.; Luo, Y. Recent Advances in the Biosynthesis of Natural Sugar Substitutes in Yeast. J. Fungi 2023, 9, 907. [Google Scholar] [CrossRef] [PubMed]
  114. Kim, H.J.; Kang, S.Y.; Park, J.J.; Kim, P. Novel activity of UDP-galactose-4-epimerase for free monosaccharide and activity improvement by active site-saturation mutagenesis. Appl. Biochem. Biotechnol. 2011, 163, 444–451. [Google Scholar] [CrossRef] [PubMed]
  115. Beerens, K.; Soetaert, W.; Desmet, T. UDP-hexose 4-epimerases: A view on structure, mechanism and substrate specificity. Carbohydr. Res. 2015, 414, 8–14. [Google Scholar] [CrossRef] [PubMed]
  116. Dai, Y.; Li, C.; Zheng, L.; Jiang, B.; Zhang, T.; Chen, J. Enhanced biosynthesis of D-tagatose from maltodextrin through modular pathway engineering of recombinant Escherichia coli. Biochem. Eng. J. 2022, 178, 108303. [Google Scholar] [CrossRef]
  117. Liu, J.J.; Zhang, G.C.; Kwak, S.; Oh, E.J.; Yun, E.J.; Chomvong, K.; Jin, Y.S. Overcoming the thermodynamic equilibrium of an isomerization reaction through oxidoreductive reactions for biotransformation. Nat. Commun. 2019, 10, 1356. [Google Scholar] [CrossRef]
  118. Rhimi, M.; Messaoud, E.B.; Borgi, M.A.; Bejar, S. Co-expression of L-arabinose isomerase and D-glucose isomerase in E. coli and development of an efficient process producing simultaneously D-tagatose and D-fructose. Enzym. Microb. Tech. 2007, 40, 1531–1537. [Google Scholar] [CrossRef]
  119. Tanase, T.; Takei, T.; Hidai, M.; Yano, S. Substrate-dependent chemoselective aldose–aldose and aldose–ketose isomerizations of carbohydrates promoted by a combination of calcium ion and monoamine. Carbohydr. Res. 2001, 333, 303–312. [Google Scholar] [CrossRef] [PubMed]
  120. Dijkmans, J.; Gabriëls, D.; Dusselier, M.; de Clippel, F.; Vanelderen, P.; Houthoofd, K.; Malfliet, A.; Pontikes, Y.; Sels, B.F. Productive sugar isomerization with highly active Sn in dealuminated β zeolites. Green. Chem. 2013, 15, 2777–2785. [Google Scholar] [CrossRef]
  121. Aburto, C.; Vera, C.; Arenas, F.; Illanes, A.; Guerrero, C. One-pot production of tagatose using l-arabinose isomerase from Thermotoga maritima and β-galactosidase from Aspergillus oryzae. Lebensm. Wiss. Technol. 2024, 194, 115. [Google Scholar] [CrossRef]
Figure 1. Chemical structures of D-tagatose, D-fructose, D-galactose, and D-sorbose. The caloric value refers to the amount of heat (in kcal) produced by consuming one gram of sugar, and the relative sweetness is compared with sucrose as the standard.
Figure 1. Chemical structures of D-tagatose, D-fructose, D-galactose, and D-sorbose. The caloric value refers to the amount of heat (in kcal) produced by consuming one gram of sugar, and the relative sweetness is compared with sucrose as the standard.
Fermentation 11 00046 g001
Figure 2. The protein sequence, crystal structure, and active center of E. coli L-AI. (A) Protein sequence, (B) crystal structure of E. coli L-AI monomer prediction of active centers, and (C) related amino acids.
Figure 2. The protein sequence, crystal structure, and active center of E. coli L-AI. (A) Protein sequence, (B) crystal structure of E. coli L-AI monomer prediction of active centers, and (C) related amino acids.
Fermentation 11 00046 g002
Figure 4. Biosynthesis of D-tagatose using starch-based ingredients as substrate through an in vivo multi-enzyme system. agp, a-Glucan phosphorylase; pgm, phosphoglucomutase; pgi, glucose 6-phosphate isomerase; gatZ, tagatose 1,6-bisposphate aldolase subunit GatZ; pgp, phosphoglycolate phosphatase.
Figure 4. Biosynthesis of D-tagatose using starch-based ingredients as substrate through an in vivo multi-enzyme system. agp, a-Glucan phosphorylase; pgm, phosphoglucomutase; pgi, glucose 6-phosphate isomerase; gatZ, tagatose 1,6-bisposphate aldolase subunit GatZ; pgp, phosphoglycolate phosphatase.
Fermentation 11 00046 g004
Table 1. The functions and applications of D-tagatose.
Table 1. The functions and applications of D-tagatose.
CharacteristicHealth FunctionsApplications
1/3 of the caloric value of sucroseLow energyLow-sugar foods, diet foods, and grain foods
Low calorie, difficult to metabolizeReduces blood sugarExclusive food for type II diabetic patients
Can be fermented by intestinal flora in the colonImproves intestinal floraDairy products, juice drinks, and effervescent tablets
Difficult to be utilized by microorganisms in the oral cavityAnti-cariesGum, toothpaste, and mouthwash
Easy to caramelize, heat and moisture absorption resistantAdds flavorBread, beverages, and sweets
Medical fieldCough syrup and denture adhesive
Wettability and stabilityImproves and prevents skin roughnessCosmetic moisturizers
Inhibits the growth of some phytopathogensProtects plantsPlant protection products
Table 2. Properties of L-AI from various microbial sources.
Table 2. Properties of L-AI from various microbial sources.
Microbial SourceSubstrateOptimum Temperature (°C)Optimum
pH
Metal Ion RequirementReferences
Thermoanaerobacterium brockiiD-galactose656.9Co2+[83]
Thermotoga neapolitana 5068D-galactose807.0Mn2+, Co2+[56]
Thermotoga maritimaD-galactose907.5Mn2+, Co2+[81]
Lactobacillus plantarum NC8D-galactose607.5Mn2+, Co2+[72]
Thermophilic bacterium IM6501D-galactose608.0Zn2+, Ni2+[84]
Lactobacillus plantarum CY6D-galactose506.5Mn2+[13]
Bifidobacterium adolescentisD-galactose556.5Mn2+, Fe2+, Zn2+, Ca2+[65]
Arthrobacter species 22cD-galactose528.0Mg2+, Mn2+, Ca2+[85]
Clostridium hylemonaeD-galactose507.5Mg2+[86]
G. thermodenitrificansD-galactose609.0None[55]
Bacillus coagulans NL01D-galactose607.5Mn2+, Co2+[43]
Pediococcus pentosaceus PC-5D-galactose506.0Mn2+, Co2+[71]
Bifidobacterium longum NRRL B-41409D-galactose556.0–6.5Ca2+, Mg2+[10]
Anoxybacillus flavithermusD-galactose959.5–10.5Ni2+[9]
Table 3. Research progress of D-tagatose production by chemical and biological methods.
Table 3. Research progress of D-tagatose production by chemical and biological methods.
Production MethodReagent/EnzymeOptimum Temperature (°C)SubstrateD-Tagatose (g/L)Conversion Rate (%)References
Chemical methodSupercritical ethanol180D-galactose8024[48]
CaCl2, triethylamine601 mmol/L of methanol, D-glucose3832[119]
Sn/β zeolite110D-galactose2924[46]
Magnesium aluminates110D-galactose1618–27[46]
Sn/deAl-β zeolite110D-galactose89.528.3[120]
Enzyme catalysisL-AI from E. coli30100 g/L D-galactose28.828.8[85]
L-AI from Lactobacillus plantarum35100 g/L D-galactose3939.0[55]
L-AI from G. stearothermophilus60100 g/L D-galactose30.630.6[89]
L-AI from G. thermodenitrificans60300 g/L D-galactose15852.7[55]
L-AI from Thermus sp.601.0 g/L D-galactose0.5454.0[84]
L-AI from Thermoanaerobacter mathranii65300 g/L D-galactose12642.0[82]
L-AI from B. stearothermophilus700.9 g/L D-galactose0.4348.0[57]
L-AI from Thermotaga maritima801.8 g/L D-galactose1.056.0[81]
L-AI from Thermotoga neapolitana801.8 g/L D-galactose1.2268.0[56]
Tagaturonate 3-epimerase from Thermotoga petrophila80700 g/L D-fructose21330.0[88]
Hexokinase from Saccharomyces cerevisiae50180 g/L D-fructose14480.0[93]
FbaA from E. coli
Phytase from NR
L-AI and β-galactosidase from E. coli BL2150100 g/L lactose23.523.5[73]
αGP, PGM, PGI, GatZ, and PGP from E. coli BL215020 g/L maltodextrin9.246.0[94]
Whole-cell catalysisE. coli BLT6010 g/L maltodextrin1.8818.8[109]
L. brevis sp. D-tag 1559 g/L D-galactose3.91643.5[105]
L-AI from Lactobacillus parabuchneri45140 g/L D-galactose5439.0[104]
E. coli/pETDuet-αgp-pgm and pCDFDuet-pgi-gatz-pgp6020 g/L maltodextrin3.216.0[110]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhang, H.; Mao, X.; Lu, Z.; Gao, C.; Chen, Z.; Liu, J. Advances in Biological Production of D-Tagatose: A Comprehensive Overview. Fermentation 2025, 11, 46. https://doi.org/10.3390/fermentation11020046

AMA Style

Zhang H, Mao X, Lu Z, Gao C, Chen Z, Liu J. Advances in Biological Production of D-Tagatose: A Comprehensive Overview. Fermentation. 2025; 11(2):46. https://doi.org/10.3390/fermentation11020046

Chicago/Turabian Style

Zhang, Hailin, Xinyu Mao, Zhengwu Lu, Cuijuan Gao, Zhiqun Chen, and Jingjing Liu. 2025. "Advances in Biological Production of D-Tagatose: A Comprehensive Overview" Fermentation 11, no. 2: 46. https://doi.org/10.3390/fermentation11020046

APA Style

Zhang, H., Mao, X., Lu, Z., Gao, C., Chen, Z., & Liu, J. (2025). Advances in Biological Production of D-Tagatose: A Comprehensive Overview. Fermentation, 11(2), 46. https://doi.org/10.3390/fermentation11020046

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop